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a b s t r a c t
Objectives: A systematic narrative literature review was undertaken to assess the acceptability of
childhood screening interventions to identify factors to consider when planning or modifying childhood
screening programs to maximize participation and uptake.
Study design: This is a systematic narrative literature review.
Methods: Electronic databases were searched (MEDLINE, EMBASE, PsycINFO via Ovid, CINAHL, and
Cochrane Library) to identify primary research studies that assessed screening acceptability. Studies were
categorized using an existing theoretical framework of acceptability consisting of seven constructs: af-
fective attitude, burden, ethicality, intervention coherence, opportunity costs, perceived effectiveness,
and self-efficacy. A protocol was developed and registered with PROSPERO (registration no.
CRD42018099763)
Results: The search identified 4529 studies, and 46 studies met the inclusion criteria. Most studies
involved neonatal screening. Programs identified included newborn blood spot screening (n ¼ 22),
neonatal hearing screening (n ¼ 13), Duchenne muscular dystrophy screening (n ¼ 4), cystic fibrosis
screening (n ¼ 3), screening for congenital heart defects (n ¼ 2), and others (n ¼ 2). Most studies
assessed more than one construct of acceptability. The most common constructs identified were affective
attitude (how a parent feels about the program) and intervention coherence (parental understanding of
the program, and/or the potential consequences of a confirmed diagnosis).
Conclusions: The main acceptability component identified related to parental knowledge and under-
standing of the screening process, the testing procedure(s), and consent. The emotional impact of
childhood screening mostly explored maternal anxiety. Further studies are needed to examine the
acceptability of childhood screening across the wider family unit. When planning new (or refining
existing) childhood screening programs, it is important to assess acceptability before implementation.
This should include assessment of important issues such as information needs, timing of information,
and when and where the screening should occur.
© 2021 The Author(s). Published by Elsevier Ltd on behalf of The Royal Society for Public Health. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
0/).
Introduction
Medical screening is a process whereby individuals undergo
tests to determinewhether they have, or have an increased risk of, a
health condition. During childhood, there are many health condi-
tions that can be screened for, including vision and hearing prob-
lems, heart defects, or biochemical genetic disorders. In 1968,
Wilson and Jungner1 defined criteria to be used to guide the se-
lection of health conditions to be screened. Since then, there have
been many advances in both diagnostic and therapeutic
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interventions. As such, a modified screening criterionwas proposed
by Anderman et al.2 The criteria ‘The test should be acceptable to
the population,’1 and ‘The overall benefits of screening should
outweigh the harm’2 relate to the acceptability of the screening
program. Acceptability of healthcare interventions is a challenging
construct. Sekhon et al.3 acknowledged that there is little guidance
on how to define acceptability. They defined acceptability to be ‘a
multifaceted construct that reflects the extent to which people
delivering or receiving a healthcare intervention consider it to be
appropriate, based on anticipated or experiential cognitive and
emotional responses to the intervention.’ They proposed a theo-
retical framework of acceptability. This includes affective attitude
(how an individual feels about the intervention), burden (the
perceived amount of effort that is required to participate in the
intervention), ethicality (the extent to which the intervention has
good fit with an individual's value system), intervention coherence
(the extent to which the participant understands the intervention
and how it works), opportunity costs (the extent to which benefits,
profits, or values must be given up to engage in the intervention),
perceived effectiveness (the extent to which the intervention is
perceived as likely to achieve its purpose), and self-efficacy (the
participant's confidence that he/she can perform the behavior(s)
required to participate in the intervention). For childhood
screening, there is further complexity as acceptability can be
applied to both the individual (i.e., the child) and the caregiver (i.e.,
the parent or guardian).
Over recent years, there has been increasing demand on
healthcare systems.4,5 Population growth and life expectancy has
increased, placing additional stress on existing healthcare sys-
tems.6,7 Advancements in technologies to aid diagnosis and man-
agement of health conditions have also contributed to stretched
resources.8,9 Consequently, existing and proposed interventions are
examined to ensure that they are both clinically effective and cost-
effective.10 However, the practical and ethical implications on
families and children when screening services are planned or
reviewed should also be considered.11 To our knowledge, there has
been no review that examines the acceptability of childhood
screening interventions. The overall aim of this review was to
assess the acceptability of childhood screening interventions with a
view to identifying which factors to consider when planning or
modifying childhood screening programs to maximize participa-
tion and uptake. We applied the framework outlined by Sekhon
et al.3 to establish which aspects of acceptability are most
commonly evaluated and which research methodology is used.
Methods
An information specialist was consulted in developing the
appropriate search strategy. One researcher (M.P.P.) conducted the
searches. Search terms included in the review included the
following:
i. Children (and derivatives)
ii. Screening (and derivatives)
iii. Acceptability terms
No restriction on the publication date was applied to the search
strategy. Full details of the search strategy are provided in Appendix 1.
The electronic databases searched for the systematic review were
MEDLINE, EMBASE, PsycINFO via Ovid, CINAHL, and the Cochrane Li-
brary. All databases were searched from inception. Searches were
conducted between May 1, 2018, and May 5, 2018. An updated search
was performed in January 2020 to include publications from January
2018 to January21, 2020. The followingeligibilitycriteriawasapplied to
the search results: published as a full-text original research article (i.e.,
not including abstracts, editorials, reviews, opinion pieces, or letters to
the editor), inclusion of a postnatal screening program (i.e., not ante-
natal screening), child health condition screening programs (i.e., not
adolescent and/or adult screening or the vaccination program), and
child and/or parental perspectives (i.e., not healthcare worker per-
spectives). Studies that solely included healthcareworker perspectives
were excluded. The protocol was registered with PROSPERO.12
To apply the eligibility criteria for the selection of articles from
the search results, the following steps were performed: (1) two
reviewers (M.P.P. and C.J.) undertook ‘filtering of titles’ indepen-
dently. Where there was disagreement, articles were retained, and
the abstract was scrutinized; (2) two reviewers (M.P.P. and C.J.)
undertook ‘filtering of abstracts’ independently. Where there was
disagreement, articles were retained, and the full text was scruti-
nized; and (3) ‘filtering of full-texts’ by three reviewers (M.P.P., C.J.,
and G.H.J.). Discussion and consensus had to be reached for an
article to be included within the review.
Articles to be included in the review were assessed against the
seven component constructs proposed by Sekhon et al.3 by two re-
viewers (C.J. and G.H.J.). Any disagreement was resolved through
discussion. Data were extracted by one reviewer (C.J.) using a piloted
data collection form. Studies were examined to determine whether
acceptability was assessed prospectively, concurrently, or retrospec-
tively; categorized as to which acceptability construct was assessed;
and categorized based on the study methodology. The type of child-
hood screening, country where screening occurred, and details of the
study participants (child or parent/carer) were also noted.
Results
The database searches identified 4529 references. A total of 149
full-text articles were retrieved for further examination. From these,
103 articles were rejected as they failed to meet the inclusion criteria.
A total of 46 publications are included in this review (see Fig. 1). The
summary of findings for the included studies is shown in Table 1.
Of the 47 studies included in the review, most were conducted
in the United States of America (USA) (n¼ 14), the United Kingdom
(UK) (n ¼ 12), the Netherlands (n ¼ 4), Australia (n ¼ 2), Canada
(n ¼ 2), and Sweden (n ¼ 2) (Table 1). The majority of studies (55%)
were published between 2010 and 2018. The content of the
screening programs included is shown in Table 1. These were
newborn blood spot screening (to identify biochemical and endo-
crine genetic disorders) (n ¼ 22), neonatal hearing screening
(n ¼ 13), Duchenne muscular dystrophy (DMD) screening (n ¼ 4),
cystic fibrosis screening (n ¼ 3), screening for congenital heart
defects (n ¼ 2), screening for congenital hypothyroidism (n ¼ 1),
and screening for hip dysplasia (n ¼ 1). The details of which
biochemical and endocrine genetic disorders were screened as part
of newborn blood spot screening programs were not clearly re-
ported, but the program typically included screening for conditions
such as phenylketonuria and sickle cell disease, among others. Most
of the studies (n ¼ 44) concerned neonatal screening.
Acceptability was assessed quantitatively (n ¼ 30), qualitatively
(n ¼ 26), and by a combination of methods (n ¼ 10). Of the studies
that adopted quantitative methods, the majority of studies used
their own questions or questionnaire, or modified existing ques-
tionnaires. Some studies did include validated questionnaires,
including the Beck Anxiety Inventory, State-Trait Anxiety Inventory
questionnaire, Center for Epidemiological Studies Depression Scale,
the depression scale of the Hospital Anxiety and Depression Scale,
the Parenting Stress Index, and the General Health Questionnaire.
Of the studies that adopted qualitative methods (n ¼ 26), most
involved interviews (n ¼ 13) and seven studies undertook focus
group sessions (n ¼ 7). Some studies issued questionnaires that
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incorporated some open-ended questions, and the free text was
analyzed qualitatively (n ¼ 8) (see Table 2).
Table 3 shows only three studies assessed acceptability at the
time of screening.13e15 The majority of studies assessed accept-
ability retrospectively (n ¼ 40).13,14,16e52 Ten studies assessed
acceptability prospectively.24,28,31,35,46,53e57 The majority of studies
examined acceptability with respect to affective attitude (n ¼ 41)
and intervention coherence (n¼ 31). Other acceptability constructs
assessed included burden (n ¼ 9), ethicality (n ¼ 5), perceived
effectiveness (n ¼ 9), opportunity costs (n ¼ 6), and self-efficacy
(n ¼ 4). Most of the studies assessed more than one construct of
acceptability. No study assessed all seven acceptability constructs
(Fig. 2).
Affective attitude
In the context of screening, this is how a parent feels about the
screening program itself. A total of 41 studies that assessed this
concept were identified.13e17,19,21,24e31,33e35,38e47,49e58 Most of the
studies also included some form of assessment of parental beliefs
on whether screening was thought to be of value.31,39,41,58 Other
studies also reported on parental satisfaction, specifically for
screening service, be it in terms of receiving results or the
screening test(s) not causing any discomfort to the parents'
child.17,19,33 Not all participants within the studies reported
favorably. Tariq et al.46 reported some parents (n ¼ 10, 4%) to view
the test for congenital hypothyroidism to be ‘unimportant,’ with
some parents (n ¼ 8, 3%) considering it to be a painful procedure
for their child.
Burden
Nine studies explored the impact of burden.16,30,33,34,40,43,52,54,57
The burden associated with screening varies from one screening
program to another. The amount of effort required for the parent/
caregiver to support the intervention (i.e., take the child for testing)
can be considered as burdensome. When screening can occur in
venues that requiredminimal effort from the parent (i.e., within the
hospital or in the home), the acceptability of the screening is
increased.30,40,52 The burden of attending the appointments owing
towork commitments or difficulties with transport can lead to non-
attendance.43 Financial burdenmay also be a factor as some parents
reported their medical insurance did not cover the screening
test(s).16,34,43 Some studies inferred burden by parental observa-
tions of discomfort of testing on the child.33
Ethicality
Nine studies were categorized as assessing
ethicality.13,19,28,30,40e42,49,57 Some studies included assessments of
beliefs with regard to the screening, including moral and religious
views.13,42,49 Parsons et al.13 reported some mothers consented to
screening for DMD as they approved of all screening. In a separate
study, Parsons et al.40 highlighted some mothers felt so positively to-
ward newborn screening that they felt it should be made compulsory.
Intervention coherence
Thirty-one studies identified within this review investigated
parental understanding of the screening program itself, and/or the
potential consequences of a confirmed diagnosis of the target
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and abstract (n = 4529)
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Fig. 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2009 Flow Diagram: study identification.
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Table 1
Summary of findings of the included studies.
Reference Year Country in which
screening occurred
Condition Age of the child
subjected to
screening
N (no. of mothers) Aim Summary
Akilan et al.16 2014 South India Hearing <2 yearsa 83 (83) To review an existing rural community-based
screening project
Community leaders played an important role in
facilitating better coverage.
Al-Sulaiman et al.17 2015 Saudi Arabia NBS Newborna 425 (425) To assess the attitude and knowledge of
mothers toward the NBS program
Positive attitude toward the NBS program;
however, better communication is needed to
increase awareness.
Araia et al.18 2012 Canada NBS Newborn, 24
e72 hrs after birth
750 (750) To identify elements of NBS education and their
associations with mothers' knowledge and
satisfaction levels
Education and information before screening is
important, particularly on the purpose, benefits,
process, and possible results of screening.
Christie et al.53 2013 Australia NBS for FXS Newborn, 24
e72 hrs after birth
1971 (1971) To determine feasibility and accuracy of two
concurrent testing methodologies; to
determine postnatal mothers' acceptance and
attitudes to screening and reasons for accepting
or declining participation; to assess the impact
of diagnosis of a child with an abnormal result
Mothers considered an early diagnosis
beneficial. Some were anxious about potential
test results; others felt their feelings toward
their newborn may change if he/she was
diagnosed positive. High participation rates and
maternal attitudes indicate a high level of
maternal acceptance and support for screening.
Crockett et al.19 2005 UK Hearing Newborn OAE




90 (90) To compare the impact of two screening tests
(newborn hearing screening e OAE test and
HVDT) and screening recall on maternal anxiety
and satisfaction
No significant differences were found (with
respect to maternal anxiety, worry, and
certainty) between the two tests.
Crockett et al.20 2006 UK Hearing Newborn within
48 h of birth
344 (344) To describe the impact of newborn screening on
maternal anxiety and to examine the impact of
knowledge
Understanding the three screening recall
systems may avoid some anxiety.
Cyrus et al.21 2012 USA DMD 12 months 138 (120) To assess the desirability of DMD screening, the
effectiveness of the consent process, and the
feasibility of screening in a pediatric office (i.e.,
after the newborn period)
Parents indicated broad support of screening.
Parents understood the risks and benefits of




2006 USA Hearing Newborna 36 (NR) To assess parents' perceptions of an emerging
community-based program in which screening
and/or follow-up testing was provided on an
‘outpatient’ basis through a private practice
Parents were generally positive about all phases
of screening. Findings were consistent with
those reported from hospital-based programs.
Davis et al.23 2006 USA NBS Newborna 51 (48) To gather opinions about the content and
timing of newborn screening education to
inform recommendations
Parents had limited knowledge and awareness
of NBS. Parents wanted concise information on
all aspects of screening including benefits, need
for retesting, and importance of follow-up (if
required). Parents wanted verbal information
from the provider and brochures. Parents felt
information should be provided in the third
trimester of pregnancy.
Detmar et al.24 2007 Netherlands NBS 1st week of life 29 (22) To investigate the preferences and views of
parents and future parents with respect to
information about, and consent to, neonatal
screening and the possible expansion of the
program
Parents were not well informed about what the
test involves and viewed it as a routine
procedure. If the program was to be expanded,
parents would like to be informed earlier,
preferably during pregnancy. Most parents
preferred an opt-out consent approach.
Din et al.54 2011 USA NBS CMV infection Newborna 3922 (NR) To assess attitudes toward newborn screening
for CMV
Among most parents, costs, worry, and anxiety
associated with newborn screening for CMV
would be acceptable. A minority of the parents
weakly opposed to newborn screening for CMV.
Etchegary et al.25 2016 Canada NBS Newborna 32 (30) To explore parent and HCP experiences of NBS
practices
Three themes were identified: offer of consent;
content and timing of information; and
importance of parental experiences for consent
decisions. NBS was viewed as ‘routine,’ with
little evidence of an informed consent process.














































Table 1 (continued )
Reference Year Country in which
screening occurred
Condition Age of the child
subjected to
screening
N (no. of mothers) Aim Summary
All participants felt information should be given
before birth.
Fitzgerald et al.55 2017 Ireland NBS Newborna 662 (662) To determine if antenatal women received
information about NBS in the antenatal period
and to evaluate their knowledge and attitudes
about NBS
Information given about NBS in the antenatal
period is inconsistent; consequently, awareness
is limited. Mothers require information to be
provided in a more structured format.
Hargreaves et al.26 2005 UK NBS Newborna 47 (42) To examine parents' and HCPs' views on
informed choice in NBS and assess information
and communication needs
Parents and HCPs recognize a tension between
informed choice in NBS and PH screening in
children. Clear, brief, and accurate parent
information and effective communication
between HCPs and parents, which take into
account parents' information needs, are
required for informed choice.
Hergils and
Hergils27
2000 Sweden Hearing Newborna 83 (NR) To assess parental attitudes and concern of
relation to universal NHS by OAE testing
Parents wanted early detection of hearing loss
and the possibility of early intervention.
Screening did not disturb the children. Most
parents' experiences of NHS were positive and
felt reassured by it.
Jatto et al.56 2018 Nigeria Hearing Newborna 48 (48) To determine the knowledge and perceptions of
mothers of newborn children on hearing
screening
Awareness of newborn screening was poor.
Willingness to accept screening increased with
increasing levels of education and increasing
levels of socio-economic status. Knowledge of
what factors are responsible for childhood
hearing loss was poor.
Joseph et al.28 2016 USA NBS Newborna 31 (31) To examine the perspectives and values of
diverse healthy pregnant women and parents of
children diagnosed with a primary
immunodeficiency disorder about traditional
NBS and expanded NBS with the use of whole-
genome sequencing.
Four themes emerged: (1) perspectives on
traditional NBS, (2) informed consent, (3) return
of results, and (4) storage and retrieval of
results. Study participants desired greater
inclusion in the NBS process. Parents voiced
concerns about privacy and control over test
results because of limited trust in the medical
system and the state-run NBS program.
Khairi et al.29 2011 Malaysia Hearing Newborna 78 (78) To investigate maternal anxiety when the child
had failed the test in the first stage of the UNHS
FP test results of the UNHS increased maternal
anxiety.
Lam et al.30 2018 Hong Kong Hearing Newborna 102 (102) To investigate maternal knowledge, attitudes,
and satisfaction of the UNHS
Information on the UNHS requires further
details, particularly on implications of results
and/or infant hearing development. Many did
not understand the results.
Lang et al.31 2009 USA NBS (CF and SCD) Newborn 388 (388) To examine maternal understanding of NBS for
SCD and CF and their knowledge of the genetics,
symptoms, and treatments of both conditions.
Poor understanding of NBS, greater familiarity
with SCD, and significant knowledge gaps for
both SCD and CF were found. There are many
missed educational opportunities for educating
parents about NBS and specific conditions
included in NBS panels in both the obstetric
clinics and the nursery.
Lipstein et al.32 2010 USA NBS Newborna 45 (41) To describe how parents consider disease and
test characteristics while making decisions
about newborn screening.
Parents' preferences differed based on
experience with genetic conditions. Most
parents wanted more detailed information.
Some suggested optional testing.
Understanding parents' decision-making
processes and information needs would
support development of screening policies that
better address variations in preferences.



















































To evaluate an existing newborn hearing
screening program with regard to information
and psychological support of parents
Amajority of parents were in favor of screening,
and screening caused little anxiety. Where
more than one retest was required, parental
anxiety increased and was linked to
information needs.
Mak et al.34 2012 China NBS Newborna 172 (NR) To examine parental knowledge and attitudes
toward the expanded NBS in Hong Kong
Parents favored having the expanded NBS in
Hong Kong. Parental tolerance was high.
Parents valued parental autonomy with
informed consent and pretest counseling.
Moody and
Choudhry35
2013 UK NBS Newborn <1 week Survey, 140 (124)
FG, 29 (27)
To explore perceptions and attitudes of parents
and future parents to an expanded NBS in the
UK and the necessary information provision and
consent processes.
Parents want guaranteed information provision
with clear decision-making powers and an
awareness of the choices available to them. The
difference between the existing NBS and
expanded NBS was not considered to be
significant enough by participants to warrant
formal written, informed consent for expanded
screening.
Narayen et al.36 2017 Netherlands CHD Newborn 1 hr after
birth and at day 2/3
1172 (1172) To assess the acceptability of PO screening to
mothers after screening in the home setting
Overall, mothers were happy with the
performance of the test, thought their baby was
comfortable during screening, and did not feel
stressed while the screening was performed.
Most mothers would recommend PO and
considered the test important.
Nicholls37 2012 UK NBS Newborna 18 (16) To explore whether parents experience the
purported tension between compliance and
achieving informed consent.
Two themes emerged relating to the
voluntariness of choices: the expectation of
compliance and presentation of information to
promote compliance. In both cases, aspects of
provision were noted as negatively impacting




2013 UK NBS Newborna 12 (10) To understand the factors that influence
parental decision-making in accepting NBS
Seven factors were identified: experience,
attitudes to medicine, information-seeking
behavior, perceived knowledge, attitudes to
screening, perceived choice, and perceived
decisional quality.
Parsons et al.39 2002 UK DMD Newborna 97 (NR) To evaluate the psychosocial implications of
newborn screening for DMD
Most families with an affected boy identified
through screening were in favor of NBS (to
allow choice in future reproductive plans and
time to prepare). Anxiety levels in the screened
group were higher than in the control group,
but were normalized during the study period.
Parsons et al.58 2005 Wales (UK) DMD Newborna 1347 (NR) To assess the effect of changing a protocol for
DMD (to make the choice more explicit) as part
of NBS.
The change in protocol resulted in increased
satisfaction, awareness, and choice. No increase
in worry was found, and parents indicated they
felt a ‘greater freedom’ to refuse the test.
Parsons et al.13 2006 UK DMD Newborna 1542 (1542) To explore the reasons given by women for
their decision about an optional newborn
screening test for DMD.
Perceptions on screening were related to 3
overarching themes: screening as a routine
procedure, screening for reassurance, and
screening for disease detection.
Parsons et al.40 2007 Wales (UK) NBS Newborna 18 (18) To explore mothers' accounts of NBS and to
explore the process of consent
Information about the screening was reported
to be varied, and most mothers received this
postpartum. Issues of consent were noted, and
mothers felt that screening was perceived as
routine.
Powell et al.41 2013 UK CHD Newborna 813 (813) To assess maternal acceptability of pulse
oximetry screening for CHD in newborn infants
and to identify factors predictive of
participation in screening
Participants were mainly satisfied with
screening. Anxiety of mothers given FP results
was not significantly higher than of those given
the TN result. Different ethnic groups had
different participation readiness into the study,














































Table 1 (continued )
Reference Year Country in which
screening occurred
Condition Age of the child
subjected to
screening
N (no. of mothers) Aim Summary
which may not reflect upon whether this would
be observed in screening itself.
Quinlivan and
Suriadi42
2006 Australia NBS Newborna 200 (200) To evaluate new mothers' opinions of genetics
and newborn screening
Acceptance of screening is high, but mothers
consider the need for consent to be mandatory.
Scheepers et al.43 2014 South Africa Hearing Newborna 50 (NR) To identify reasons why parents refuse
newborn hearing screening and why some
default on follow-up rescreening
Most frequent reasons for refusing screening
were related to costs and knowledge about the
screening process.
Skinner et al.44 2011 USA NBS for FXS Newborna 1930 (1930) To document rates of parental consent in a pilot
study of screening for FXS, examine
demographic characteristics of mothers who
consented or declined, and describe the reasons
for their decision.
A majority of parents accepted screening, but
decision rates and reasons for accepting/
declining varied in part as a function of race/
ethnicity and in part as a function of what
parents most valued or feared in their
assessment of risks and benefits.
Stuart et al.45 2000 USA Hearing Newborna 40 (40) To determine whether mothers whose infants
had failed NHS had more stress than those
mothers whose infants had passed NHS
No significant difference was found between
the two groupsdthose mothers whose infant
had failed demonstrated equivalent stress
levels as those mothers whose infants had
passed.
Tariq et al.46 2018 Pakistan Congenital
hypothyroidism
Newborna 355 (355) To determine knowledge of congenital
hypothyroidism and to assess the impact of
health education on knowledge and attitudes
toward screening
Most mothers were unaware of congenital
hypothyroidism and its implications.
Awareness increased after the intervention
survey.
Tluczek et al.14 1992 USA CF (as part of NBS) Newborna 104 (66, plus 28
responses from
both parents)
To examine parental knowledge of (1) the
screening program, (2) understanding of
negative results, (3) effects of screening-related
anxieties, and (4) the effects of FP results
Parents had gaps in knowledge about screening,
misconceptions about test results, and high
levels of anxiety.
Tluczek et al.47 2005 USA CF (as part of NBS) Newborna 28 (25) To investigate the psychosocial effects on
parents of infants with abnormal results in CF
NBS that uses genetic testing
Most parents experienced high levels of
emotional distress waiting for the sweat-test
appointment (diagnostic test). Parental
uncertainty and emotional distress were
influenced by prior knowledge of NBS, CF, their
own carrier status, adjustment to having a new
baby, and physicians' approach to parents.
Tluczek et al.47 2009 USA CF (as part of NBS) Newborna 193 (100) To learn how parents were informed about NBS
and obtain their suggestions for improving the
process of educating parents about NBS
Parents described much inconsistency in the
timing of information and methods used to
inform them about NBS. Parents recommended
improving communication about NBS at
multiple points. Parents suggested that
providers take time to explain the purpose and
importance of NBS, which diseases are included
in testing, and when to expect results.
Ulph et al.49 2011 UK NBS Newborna 37 (28) To explore the origins and content of service
users' prior knowledge of universal antenatal
and newborn screening for hemoglobin
disorders.
Families influenced participants' screening
knowledge, decisions, and service use. Families
were often participants' main source of support.









To identify and compare the prevalence and
degree of maternal worry about NHS at the time
of an initial NHS and rescreening
Maternal worry was greater at the rescreening
cf. screening. Those who reported greater worry
at the time of the screening were more likely to
be socio-economically disadvantaged. Maternal
knowledge of screening increased between the
















































examined the issues of parental knowledge, receipt of information,
and previous experience of screening and experiences of friends
and/or family members. Some studies explored issues of consent,
which also included parents having sufficient information and
appropriately timed information to allow for informed consent.
Some parents recalled that newborn screening was offered as a
choice where active consent was given, whereas other parents
were less certain as to whether they did provide consent. Even
within the same study cohort, parental accounts with regard to the
issue of consent for screening varied.25 For some parents, the
screening process was ‘routinized,’ and that this can be inadver-
tently presented as compulsory.
Opportunity costs
Six articles identified issues with regard to opportunity
costs.16,23,26,34,43,54 Some studies discussed the consequences of
direct financial costs on attending screening and whether such
costs were covered by medical insurance.23,43 Some parents were
not concerned about the costs of testing, and others expressed a
willingness to pay.34,54 However, some parents stated that the
expense of additional (screening) tests would result in the refusal of
any advised additional testing.23 One study reported that atten-
dance to screeningwould come at a cost of missing work and giving
up time with other children/family responsibilities.16
Perceived effectiveness
Perceived effectiveness was studied in nine
studies.14,16,28,32,38,39,41,43,52 Some studies reported that parents
either had doubts in the effectiveness of the test, had doubts in the
accuracy of results, or even had distrust of the healthcare
system.14,32,39,41,43,52 Some parents noted that screening would not
be offered if it had not already been reviewed or assessed as being
acceptable by experts, including medical professionals.38
Self-efficacy
Four studies were categorized as assessing for self-effi-
cacy.16,23,34,52 Parents reported that while they wanted information
about the screening process, they noted that the timing the infor-
mation was received was not appropriate. They felt overwhelmed
with information and were ‘often exhausted.’23 The context of
exhaustion may be particularly pertinent to screening programs
that occur within the first few weeks/months of life. Generally,
parents were confident that they were able to arrange other re-
sponsibilities to make time to attend for screening (and/or referral)
appointments.16,34,52
Discussion
Acceptability of the childhood screening program is a relatively
under-researched area. A key objective of this review was to
identify factors to be considered to encourage participation in
childhood screening programs, thereby maximizing the program's
cost-effectiveness. Two of the most common constructs identified
from the included studies were affective attitude (how the parent
feels about the screening program) and intervention coherence
(parental understanding of the screening program itself and/or the
potential consequences of a confirmed diagnosis of the target
condition). Determining how a parent or guardian feels about
screening could be considered as an important first step when
considering implementing new (or refining existing) childhood
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negatively about the screening program, this is likely to affect
attendance and therefore efficiency of the program itself. Parental
beliefs, understanding, and knowledge of the screening program
(includingwhat it entails andwhat the potential consequencesmay
be) are influenced by information. The amount of information and
timing of information is important not only to ensure parents un-
derstand the screening process but also to ensure that informed
consent to participate in the screening program can be obtained.
23e25,35 It is therefore important to fully consider the information
needs of parents while planning and implementing childhood
screening programs.13,20,23,25,29,32,38 Information needs may differ
between groups and populations.11 A standardized approach across
a whole country may not be appropriate, and localized documents
(or other information resources) should be considered. Other issues
identified included the burden of the screening program and any
costs associated with the screening program.16,23,26,34,43,54 Accept-
ability was noted to be influenced byminimal effort in participating
in the screening process (i.e., whether the screening was under-
taken at a convenient location, such as within the hospital or in
their own home 30,40,52 and whether the costs were minimized).
When screening exists as part of a suite of health checks, this makes
the screening more acceptable to parents.11 All of these factors may
influence screening uptake and attendance. Not all costs were
noted to be direct financial costs (such as paying for the screening
tests), but could also be related to taking time to travel to the venue
where the screening is carried out, how long the screening may
take, and any loss of income due to taking time off work.16 It was
difficult to draw any firm conclusions on whether potential finan-
cial implications of attending screening could influence the
acceptability of such programs. The studies identified varied in the
country setting, from low-income countries (India)16 to upper
middle-income countries (China and South Africa)43,54 to high-
income countries (UK and USA).23,26 Consideration of how
healthcare systems are funded is important, particularly if parents
Table 2
Study methodologies of the included studies and types of data collection method(s).
Reference Both Quantitative assessment instruments Qualitative methods
Own EDS STAI IoE scale CHQ-PF28 BAI GHQ HADS PSI CES-D CST Int. FG Free-text
Akilan et al.16 7 ✓
Al-Sulaiman et al.17 7 ✓
Araia et al.18 7 ✓
Christie et al.53 ✓ ✓ ✓ ✓ ✓ ✓
Crockett et al.19 ✓ ✓ ✓
Crockett et al.20 ✓ ✓ ✓
Cyrus et al.21 ✓ ✓ ✓
Danhauer and Johnson22 ✓ ✓ ✓
Davis et al.23 7 ✓ ✓
Detmar et al.24 7 ✓
Din et al.54 7 ✓
Etchegary et al.25 7 ✓
Fitzgerald et al.55 7 ✓
Hargreaves et al.26 7 ✓ ✓
Hergils and Hergils27 7 ✓
Jatto et al.56 7 ✓
Joseph et al.28 7 ✓
Khairi et al.29 7 ✓
Lam et al.30 7 ✓
Lang et al.31 7 ✓
Lipstein et al.32 7 ✓
Magnuson and Hergils33 7 ✓
Mak et al.34 7 ✓
Moody and Choudhry35 ✓ ✓ ✓
Narayen et al.36 7 ✓
Nicholls37 7 ✓
Nicholls and Southern38 7 ✓
Parsons et al.39 ✓ ✓ ✓ ✓ ✓
Parsons et al.58 ✓ ✓ ✓
Parsons et al.13 ✓ ✓ ✓
Parsons et al.40 7 ✓
Powell et al.41 ✓ ✓ ✓ ✓ ✓
Quinlivan and Suriadi42 7 ✓
Scheepers et al.43 7 ✓
Skinner et al.44 7 ✓
Stuart et al.45 7
Tariq et al.46 7 ✓
Tluczek et al.14 7 ✓
Tluczek et al.47 ✓ ✓ ✓
Tluczek et al.47 7 ✓
Ulph et al.49 7 ✓
Vohr et al.15 7 ✓
Waisbren et al.50 7 ✓ ✓
Weichbold et al.51 7 ✓
Weinreich et al.57 ✓ ✓ ✓
Witting et al.52 7 ✓
Both ¼ the study used both quantitative and qualitative methods; EDS ¼ Edinburgh Depression Scale; STAI ¼ State-Trait Anxiety Inventory; IoE scale ¼ Impact of Event Scale;
CHQ-PF28 ¼ Child Health Questionnaire Parent Form 28 items; BAI ¼ Beck Anxiety Inventory; HADS ¼ Hospital Anxiety and Depression Scale; PSI ¼ Parenting Stress Index;
CES-D ¼ Center for Epidemiological Studies Depression Scale; CST ¼ client satisfaction tool; Int. ¼ interview; FG ¼ focus group; GHQ ¼ General Health Questionnaire.
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are meeting the financial costs of screening. Studies have shown
that socio-economic status and risk of having disease (or health
condition) do influence screening participation.11,61e63 Although it
can be hypothesized that parents with lower socio-economic status
may find screening less acceptable, the studies identified in this
review can neither support nor refute this hypothesis. Further
studies are required to fully understand the financial burden of
screening, either the cost of testing and/or the costs incurred owing
to attending screening (such as travel costs and lost income).
The studies identified in this review were conducted on small
populations. All the studies assessed acceptability from a parental
(often maternal) perspective rather than from the individual's
perspective. None of the studies explicitly explored whether
acceptability differed within different population groups (such as
ethnicity, educational status, and so on). Further research is
required to investigate the acceptability of childhood screening
programs across the wider family unit, with increased inclusion of
modern-day parenting situations and roles.
A mixture of study methodologies was used to assess childhood
screening acceptability. For the studies that used quantitative
methods, existing validated questionnaires were administered to
parents to measure anxiety associated with the screening process.
In these studies, the level of anxiety was used as a proxy for
acceptability.19,20,29,39,41,53 However, it must be acknowledged that
anxiety is in itself a multifaceted construct. Many parents find
having a new baby a stressful time, even when good support
Table 3
Assessment of acceptability and constructs included.
Reference When acceptability was assessed Component constructs of acceptability










Akilan et al.16 ✓ ✓ ✓ ✓ ✓ ✓ ✓
Al-Sulaiman et al.17 ✓ ✓ ✓
Araia et al.18 ✓ ✓
Christie et al.53 ✓ ✓
Crockett et al.19 ✓ ✓ ✓
Crockett et al.20 ✓ ✓




Davis et al.23 ✓ ✓ ✓ ✓
Detmar et al.24 ✓ ✓ ✓ ✓
Din et al.54 ✓ ✓ ✓ ✓
Etchegary et al.25 ✓ ✓ ✓
Fitzgerald et al.55 ✓ ✓ ✓
Hargreaves et al.26 ✓ ✓ ✓ ✓
Hergils and Hergils27 ✓ ✓
Jatto et al.56 ✓ ✓ ✓
Joseph et al.28 ✓ ✓ ✓ ✓ ✓ ✓
Khairi et al.29 ✓ ✓ ✓
Lam et al.30 ✓ ✓ ✓ ✓ ✓
Lang et al.31 ✓ ✓ ✓ ✓




Mak et al.34 ✓ ✓ ✓ ✓ ✓ ✓
Moody and
Choudhry35
✓ ✓ ✓ ✓




✓ ✓ ✓ ✓
Parsons et al.39 ✓ ✓ ✓
Parsons et al.58 ✓ ✓ ✓
Parsons et al.13 ✓ ✓ ✓ ✓
Parsons et al.40 ✓ ✓ ✓ ✓ ✓




Scheepers et al.43 ✓ ✓ ✓ ✓ ✓ ✓
Skinner et al.44 ✓ ✓
Stuart et al.45 ✓ ✓
Tariq et al.46 ✓ ✓ ✓ ✓
Tluczek et al.14 ✓ ✓ ✓ ✓ ✓
Tluczek et al.47 ✓ ✓ ✓
Tluczek et al.47 ✓ ✓
Ulph et al.49 ✓ ✓ ✓ ✓
Vohr et al.15 ✓ ✓
Waisbren et al.50 ✓ ✓ ✓
Weichbold et al.51 ✓ ✓ ✓
Weinreich et al.57 ✓ ✓ ✓ ✓
Witting et al.52 ✓ ✓ ✓ ✓ ✓ ✓
J. Carlton, H.J. Griffiths, A.M. Horwood et al. Public Health 193 (2021) 126e138
135
networks (such as friends and family) are in place. Increased levels
of anxiety with regard to the time of neonatal screening may occur
irrespective of whether a parent has anxiety with regard to the
screening itself. Therefore, quantifying anxiety using an existing
questionnaire(s) may not be the most appropriate method to un-
derstand what impact childhood screening has on a parent. To fully
understand the individual's behaviors and feelings, qualitative
research methods are required. The use of qualitative research
methods facilitates an in-depth understanding of behavior and the
reasons that govern that behavior64 and may provide deeper
insight into how parents feel about childhood screening programs.
The majority of the studies identified in the review were
retrospective in nature, and the results perhaps should be treated
with caution. The parental perspective of acceptability may have
been influenced by the outcome of the screening program itself,
that is, whether the child is found to have (or not) the condition for
which the child was screened. This factor was not always disclosed
in the included studies. Some may argue that acceptability is linked
to satisfaction; however, Sekhon et al.3 state there is a difference
between these concepts. They argue that satisfaction can only be
assessed retrospectively, whereas acceptability can be assessed
both retrospectively and prospectively. Another important issue
relating to retrospective assessment of acceptability is the timing of
assessment in relation to the screening episode, i.e., how ‘retro-
spective.’ Recall bias is an important consideration when inter-
preting the results of any study.65,66 Future studies will need to
determine whether any impact of acceptability is present only in
the short term (i.e., soon after the screening intervention) or more
in the long term (i.e., months or even 1 year after screening). For
example, issues of exhaustion and poor timing and information
overload16,23,34,52 may only be apparent or measurable if accept-
ability is assessed in the short term.
Limitations
This review is not without its limitations. Owing to the limited
number of studies identified, no assessment (and therefore re-
striction) of study quality was performed. It is possible that bias
exists within the studies, and the conclusions of individual study
findings should be considered against issues such as design bias,
sampling bias, measurement bias, interview bias, response bias,
and reporting bias. The varied study outcomes and methodologies
meant that meta-analysis and synthesis beyond a narrative review
was not possible. A further limitation is that of acceptability
construct categorization. Some of the constructs within the
framework are linked, for example, burden and opportunity costs.
The burden of attending a screening program may include time
(which may include time off work, which could incur a cost), travel
(which will incur a cost), and psychological burden (such as anxiety
or worry). Affective attitude and perceived effectiveness are also
related. Both constructs are associated with parental knowledge
and understanding and information needs. Intervention coherence
may relate to parental understanding of what the screening test(s)
involves, any risks associated with the test(s), the consequence of a
‘positive’ screening result, consent for the screening test(s) to take
place, and the effect involved in consenting to the screening pro-
gram. Perceived effectiveness of screening centers on how well/
accurate the screening test(s) is in being able to provide an indi-
cation of whether a child has the target condition, i.e., is the
screening going to work? Similarly, affective attitude and ethicality
are also linked. Although studies were assessed by two reviewers,
there were inconsistencies with categorizations. Disagreements
occurred when the results of the included studies could infer
assessment of a construct (i.e., parental feelings of the screening
program could infer the ethicality of screening). Most studies
concerned neonatal screening. The findings may not apply to
screening in older children. The acceptability of screening in older
children may include other constructs, and the perspective of the
child could also be considered.
Conclusions
Acceptability of childhood screening programs is an under-
researched area. The aim of the review was to assess the accept-
ability of childhood screening interventions with a view to identify
which factors to consider when planning or modifying childhood
screening programs to maximize participation and uptake. We
identified that in the context of childhood screening programs,
acceptability was often determined by assessing parental knowl-
edge and understanding of the screening process, the testing pro-
cedure(s), and consent. The emotional impact of childhood
screening explored maternal anxiety levels associated with the
timing of the screening process and the impact of any false referral.
There are evidence gaps, and further studies are required to
examine the acceptability of childhood screening across the wider
family unit, including the child themselves (for screening in older
children). While planning new (or refining existing) childhood
screening programs, it is important to assess acceptability before
Fig. 2. Number of acceptability constructs reported within identified studies.
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any implementation. The results of such studies can then inform
and address issues such as information needs, timing of informa-
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